The high-molecular-mass neurofilament subunit (NFH) is normally hypophosphorylated in the neuronal perikaryon and undergoes extensive phosphorylation after entering the initial axon segment. Aberrant hyperphosphorylation of perikaryal NFH is a common feature of many neurological diseases. In a previous study (Giasson and Mushynski, 1996) , we demonstrated a correlation between phosphorylation of perikaryal NFH and induction of stress-activated protein kinase (SAPK)-␥. In this report, we present direct evidence showing that the in vivo activation of SAPKs by an upstream activator (MEKK-1) caused extensive NFH phosphorylation. We also show that stress-activated p38 kinases were not involved in the phosphorylation of perikaryal NFH in cultured dorsal root ganglion neurons and that this process was reversible. SAPK␥ was shown to be located in both the cell body and the neurites of the cultured neurons, suggesting that it is likely to be involved in the phosphorylation of cytoplasmic substrates. These could include neuritic NFH, which is highly phosphorylated despite the demonstrated lack of cyclin-dependent kinase-5 activity in these neurons. Neuritic NFH was also highly phosphorylated in neuronal cultures devoid of Schwann cells, indicating that this form of post-translational modification does not require cues stemming from Schwann cell-axon contacts. Collectively, these findings provide significant new insights into mechanisms involved in NFH phosphorylation in normal neurons and in disease states characterized by aberrant phosphorylation of neurofilaments.
Neurofilaments (N Fs) are the principal intermediate filaments (IFs) found in many types of mature neurons. They are the most abundant structure in large myelinated axons (Hoffman et al., 1984) and are an important determinant of axonal caliber (Yamasaki et al., 1991; Ohara et al., 1993; Eyer and Peterson, 1994) . NFs are composed of three proteins, the low (N FL)-, mid-sized (NFM)-, and heav y (N F H)-molecular-mass subunits (Hoffman and Lasek, 1975) . In common with other I F proteins, each NF subunit contains a highly conserved ␣-helical rod domain, involved in dimer formation, flanked by an N-terminal head domain and a C -terminal tail domain (Fuchs and Weber, 1994) .
N F H from myelinated axons is highly phosphorylated in vivo (Julien and Mushynski, 1982) , predominantly at Lys-Ser-Pro (KSP) repeats in the tail domain (Julien and Mushynski, 1983; Lee et al., 1988; Elhanany et al., 1994) . The role of NFH tail domain phosphorylation is not f ully understood, although it has been shown to inhibit interaction between N F H and microtubules (Hisanaga et al., 1991 (Hisanaga et al., , 1993a Miyasaka et al., 1993) and to protect N F H from proteolysis (Goldstein et al., 1987; Pant, 1988) . It may also regulate the distribution of NFs between stationary and mobile phases in the axon (Lewis and Nixon, 1988) .
The use of monoclonal antibodies that could distinguish between phosphorylated and unphosphorylated epitopes in the tail domain of NFH has shown that axonal NFH is normally more highly phosphorylated than that located in the cell body and dendrites (Sternberger and Sternberger, 1983; Lee et al., 1987) . Perikaryal NFH is maintained in a hypophosphorylated state with M r 160 kDa on SDS-PAGE compared with a value of 200 kDa for axonal NFH (Glicksman et al., 1987; Oblinger, 1987; Nixon et al., 1989) . The gel electrophoretic mobility of axonal NFH increases to that of perikaryal NFH after dephosphorylation of the tail domain (Julien and Mushynski, 1982; Carden et al., 1985) , and this shift is reversed by phosphorylation at KSP repeats (Hisanaga et al., 1991 (Hisanaga et al., , 1993b Miyasaka et al., 1993) . Of the neuronal proline-directed protein kinases that can phosphorylate NFH, only tau protein kinase II/cyclin-dependent kinase-5 (cdk-5) has been shown unequivocally to cause a reduction in its mobility on SDS-PAGE to levels seen for axonal NFH (Hisanaga et al., 1993b; Kobayashi et al., 1993; Miyasaka et al., 1993; Guidato, 1996a; Sun et al., 1996) .
Perikaryal N F H is highly phosphorylated in many neurodegenerative diseases, such as Alzheimer's disease (Cork et al., 1986; Z hang et al., 1989 ), Parkinson's disease (Forno et al., 1986; Pollanen et al., 1994) , and amyotrophic lateral sclerosis (AL S) (Manetto et al., 1988; Munoz et al., 1988; Sobue et al., 1990) . We previously presented correlative evidence indicating that stress-activated protein kinase-␥ (SAPK␥) could be responsible for the aberrant phosphorylation of perikaryal N F H (Giasson and Mushynski, 1996) . SAPK s are proline-directed kinases belonging to the mitogen-activated protein (M AP) kinase family, which also includes extracellular signalregulated kinases (ERK s), p38 kinases (C ano and Mahadevan, 1995; Kyriakis and Avruch, 1996) , and a novel member, SAPK-3 (Mertens et al., 1996) . The M AP kinases are related structurally and are activated by similar cascades in response to diverse stimuli (C ano and Mahadevan, 1995; Kyriakis and Avruch, 1996) .
In this report, we present direct evidence that the in vivo activation of SAPK s by constitutively active M AP kinase/ERK kinase kinase-1 (M EK K-1) induces phosphorylation of the NFH tail domain. We also show that p38 kinases are not involved in the hyperphosphorylation of perikaryal N F H and that this process is completely reversible. These findings provide basic information that enhances our understanding of mechanisms causing aberrant NF phosphorylation in neurological diseases.
MATERIALS AND METHODS

Materials.
Nerve growth factor (NGF) (2.5S) was purchased from Prince Laboratories (Toronto, Ontario, C anada). Anti-N F antibodies SM I 31 and SM I 34 were obtained from Sternberger Monoclonals (Baltimore, MD). Anti-SAPK␥ (C -17), anti-ERK-1 (C -16), anti-ERK-2 (C -14), antip38␣ (C -20), anti-cdk-5 (C -8) polyclonal antibodies, anti-cdk-5 (DC17) monoclonal antibody, and glutathione S-transferase (GST)-cJun (amino acids 1-79) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Histone H1 was obtained from Life Technologies (Gaithersburg, MD). The pRC /C M V eukaryotic expression vector was purchased from Invitrogen (San Diego, CA). Anti-N F H (N52) and anti-N FL (N R4) monoclonal antibodies were from Sigma (St. L ouis, MO). Polyclonal anti-vimentin antibody and N-acetyl-Leu-Leu-norleucinal (CI) were from IC N (Mississauga, Ontario, C anada). SB 203580 was generously provided by SmithK line Beecham.
Cell culture. Embryonic day 15-16 dorsal root ganglia (DRGs) were dissected, dissociated, and maintained in culture as described previously (Giasson and Mushynski, 1996) . To allow for the manual separation of cell bodies from neurites, the dissociated DRGs were plated in a small area at the center of a 35 mm culture dish. Neurites extended radially to form a halo surrounding the cell body mass. N IH 3T3 cells were obtained from the American T ype Culture Collection (Rockville, MD) and cultured in 85% DM EM (high glucose), 10% heat-inactivated horse serum, 5% fetal bovine serum (Life Technologies), and antibiotics. The cells were transfected using lipofectamine reagent (Life Technologies) according to the manufacturer's instructions.
Immunoprecipitation k inase assays. SAPK␥ activity was assayed as described previously (Giasson and Mushynski, 1996) . Briefly, after cell lysis in the presence of Triton X-100, cell debris was removed by centrif ugation at 13,000 ϫ g and the protein concentration of each supernatant was determined to equalize the amount of protein used in each immunoprecipitation. SAPK␥ was immunoprecipitated, the immunoprecipitates were washed extensively, and activity was assayed using [␥- 32 P]ATP and GST-cJun as a substrate. Phosphorylation of GST-cJun was visualized after SDS-PAGE (Laemmli, 1970) by autoradiography of dried gels and quantified using a Fujix BAS2000 Bio-Imaging Analyzer (Fuji Bio-Imaging).
C dk-5 activity was assayed by immunoprecipitation kinase assay as described previously (Tsai et al., 1993) using an anti-cdk-5 polyclonal antibody (C -8) and histone H1 as the substrate. Visualization of the phosphorylated substrate was achieved as described for SAPK␥.
Gel electrophoresis and Western blot anal ysis. C ells were harvested in PBS (137 mM NaC l, 2.7 mM KC l, 10 mM Na 2 HPO 4 , and 1.8 mM KH 2 PO 4 ) and lysed in 2% SDS and 62.5 mM Tris, pH 6.8, and protein concentration was determined using the bicinchoninic acid (BCA) assay (Pierce, Rockford, IL). Glycerol and ␤-mercaptoethanol were added to concentrations of 10 and 5%, respectively. The cell extracts were diluted to the appropriate concentrations with SDS-sample buffer (2% SDS, 62.5 mM Tris, pH 6.8, 10% glycerol, and 5% ␤-mercaptoethanol), and the proteins were resolved on slab gels by SDS-PAGE (Laemmli, 1970) . Proteins were transferred electrophoretically to Immobilon-P membrane (Millipore, Bedford, M A) in buffer containing 48 mM Tris, 39 mM glycine, and 5% methanol. The membranes were blocked with 1% skimmed milk powder in Tris-buffered saline/ T ween (20 mM Tris, pH 7.7, 137 mM NaC l, and 0.1% T ween 20), incubated with primary antibodies, and developed using the ECL Western Blotting Detection K it (Amersham).
RESULTS
Transfection of cells with MEKK-1⌬ induces NFH tail domain phosphorylation
MEKK-1⌬, a constitutively active form of MEKK-1 that serves as an activator of the SAPK cascade (Minden et al., 1994; Yan et al., 1994; Xu et al., 1995) , was tested for its ability to induce NFH phosphorylation in vivo. NIH 3T3 cells transfected with the expression vector pRC/CMV alone did not express NFH ( Fig.  1 A, lane 1) . In extracts from cells transfected with the expression vector containing the mouse NFH gene (Julien et al., 1988) beginning 15 nucleotides upstream from the translational start site, NFH was detected with N52 antibody as a predominantly hypophosphorylated isoform(s), judging from its mobility on SDS-PAGE and from its failure to bind monoclonal antibodies SMI 31 or SMI 34 ( Fig. 1 A, lane 2) . Monoclonal antibody N52 can detect both hypo-and hyperphosphorylated forms of NFH (Shaw et al., 1986) , although the relevant epitope can be blocked by cdk-5 phosphorylation (Guidato et al., 1996b) . SMI 31 and SMI 34 are both phosphorylation-dependent monoclonal antibodies that react with different epitopes in the tail domain of NFH (Sternberger and Sternberger, 1983; Lee et al., 1988; Shea and Beermann, 1993) . Cotransfection of NIH 3T3 cells with pRC/CMV vectors expressing NFH and MEKK-1⌬ yielded hy- perphosphorylated N F H, as determined by its reduced mobility on SDS-PAGE and by its reactivity with both SM I 31 and SMI 34 ( Fig. 1 A, lane 3) . The expression of M EK K-1⌬ also resulted in the activation of SAPK␥ (Fig. 1 B) .
P38 kinases are not involved in stress-induced NFH phosphorylation
Proline-directed p38 kinases are often activated simultaneously with SAPK s (C ano and Mahadevan, 1995; Raingeaud et al., 1995) . To test whether p38 kinases are also involved in the hyperphosphorylation of perikaryal N F H, we used a specific inhibitor, SB 203580 (IC 50 0.6 M), which does not inhibit SAPKs (Cuenda et al., 1995) . Cultured DRG neurons were treated with 30 M CI, a calpain (Saito and Nixon, 1993) and proteasome inhibitor (Tsubuki et al., 1993; Rock et al., 1994) , which has been shown to activate SAPK and induce hyperphosphorylation of perikaryal N F H (Giasson and Mushynski, 1996) (Fig. 2, lane 2) . The addition of 20 M SB 203580 had no effect on the CI-induced reduction in mobility, and therefore phosphorylation, of NFH (Fig. 2, lane 3) .
Distribution of MAP kinases in DRG neurons
The distribution of M AP kinases within DRG neurons was assessed by Western blot analysis as shown in Figure 3 . DRG cultures maintained in medium containing antimitotic agents were fractionated into neurite (lane 1)-and cell body (lane 2)-enriched fractions as described in Materials and Methods. The antimitotic agents eliminated all of the Schwann cells normally found in DRG cultures and prevented the proliferation of fibroblasts. However, the cultures still contained a population of quiescent fibroblasts resistant to antimitotic treatment. To compensate for contamination by these fibroblasts, we prepared DRG cultures treated with antimitotic agents and maintained without NGF to eliminate neurons (Giasson and Mushynski, 1997) . Lane 3 in Figure 3 was loaded with an amount of protein from fibroblast cultures equal to that for neurite (lane 1) and cell body (lane 2)-enriched fractions. Lanes 4 -6 were loaded, respectively, with two-, four-, and eightfold less fibroblast protein than lane 3. The inclusion of lanes 3-6 allowed us to determine whether the proteins detected in lanes 1 and 2 were neuronal in origin or from contaminating fibroblasts. Vimentin and N FL were used as specific markers for fibroblasts and DRG neurons, respectively. There were equivalent amounts of N FL in the neuronal cell bodyand neurite fractions, and N FL was not detected in cultures maintained without NGF. T wo other DRG neuronal markers, peripherin and ␣-internexin (Athlan et al., 1997) , also were not detected in the fibroblast cultures (data not shown). There were approximately equal levels of fibroblast contamination in the neuronal cell body and neurite fractions as determined by their vimentin content, and these fractions contained Ͻ12% fibroblast protein. P38␣ was expressed at low levels in DRG neurons and only in the cell body fraction. ERK-1/-2 and SAPK␥ were equally distributed between the cell body and neurite fractions.
The hyperphosphorylation of perikaryal NFH is reversible
Cultured DRG neurons were treated with 30 M CI to induce the hyperphosphorylation of perikaryal NFH (Giasson and Mushynski, 1996) , as reflected in its reduced mobility on SDS-PAGE (Fig.  4, lane 2) . After removal of CI from the culture medium, perikaryal NFH was seen to undergo progressive dephosphorylation. Approximately half of the protein had returned to its normal mobility on SDS-PAGE within 2 d (Fig. 4, lane 3) ; by 4 d, almost all of the NFH had return to a normal hypophosphorylated state (Fig. 4, lane 4 ) .
Axonal NFH in DRG neurons is hyperphosphorylated despite the inactivity of cdk-5
The Western blots in Figure 5A show that most of the NFH in the neuronal cell body-enriched fraction was hypophosphorylated, whereas that in the neurite-enriched fraction was mostly hyperphosphorylated. The small amount of hypophosphorylated NFH in the neurite-enriched fraction originates from neuronal cell bodies localized outside of the circumference of the circular punch used to separate the two neuronal compartments. The were loaded with 5 g of protein, whereas lanes 4-6 were loaded with 2.5 g, 1.25 g, and 0.62 g of protein, respectively. The proteins were detected by Western blot analysis. NFL, Vim, SA PK␥, ERK1, ERK2, and p38 refer to the low-molecular-mass neurofilament subunit, vimentin, SAPK␥, ERK-1, ERK-2, and p38␣ kinase, respectively. hyperphosphorylated N F H in cell body-enriched extracts derives from the initial segment of neurites and from neurites crisscrossing the area occupied by the cell body mass. The slowly migrating, highly phosphorylated isoforms of N F H reacted with both phosphorylation-dependent antibodies, SM I 31 and SMI 34. Therefore, N F H in cultured DRG neurons demonstrated the normal phosphorylation pattern (Sternberger and Sternberger, 1983; Glicksman et al., 1987; Lee et al., 1987; Oblinger, 1987; Nixon et al., 1989) , which was also observed in DRG cultures treated with antimitotic agents and devoid of Schwann cells (Fig. 5B) .
The activity of cdk-5 in cultured DRG neurons was determined by immunoprecipitation kinase assays using rat brain extract as a positive control (Fig. 6 A, lanes 1-6 ) (Tsai et al., 1993) . Because the relative amounts of immunoprecipitable cdk-5 in brain extract compared with extract from DRG cultures were unknown, different amounts of rat brain extract were used in the immunoprecipitation kinase assays, and levels of immunoprecipitated cdk-5 were determined by Western blot analysis (Fig. 6 B) . Despite the fact that comparable amounts of cdk-5 were immunoprecipitated from 200 g of DRG extract and 100 g of brain extract (Fig. 6 B,  lanes 4, 8) , no histone H1-phosphorylating activity was detected in DRG samples (Fig. 6 A, lane 8) . Western blot analysis of total protein extracts from rat brain and DRG cultures revealed that, on an equal protein basis, rat brain contained approximately twice as much cdk-5 as did the DRG cultures (data not shown).
DISCUSSION
This study presents direct evidence that SAPKs can phosphorylate the tail domain of NFH, as reflected both in the reduced mobility of NFH on SDS-PAGE and in its immunoreactivity with the phosphorylation-dependent monoclonal antibodies SMI 31 and SMI 34 (Fig. 1) . SAPK activation was accomplished by transfection of a vector expressing constitutively active MEKK-1⌬, which activates JNK kinase (JNKK/MKK4/SEK4), the upstream regulator of SAPKs (Yan et al., 1994; Dérijard et al., 1995; Lin et al., 1995) . Although MEKK1 can also activate the ERK pathway (Lange-Carter and Johnson, 1994; Xu et al., 1995) , it is a more efficient activator of the SAPK cascade (Minden et al., 1994; Yan et al., 1994) . Furthermore, we previously demonstrated that ERK activation did not result in a detectable increase in the in vivo phosphorylation of NFH (Giasson and Mushynski, 1996) , and others have shown that the in vitro phosphorylation of NFH by ERKs did not cause a significant reduction in its mobility on SDS-PAGE (Roder and Ingram, 1991; Roder et al., 1995) . Use of a specific inhibitor of p38 kinases, SB 203580, demonstrated that the latter enzymes are not involved in the hyperphosphorylation of perikaryal NFH (see Fig. 2 ). These results support our previously reported correlative study (Giasson and Mushynski, 1996) and strongly suggest that SAPKs are involved in the aberrant phosphorylation of perikaryal NFH.
The stress-activated phosphorylation of perikaryal NFH is completely reversible (see Fig. 4 ), indicating that a protein phosphatase(s) in the neuronal perikaryon can maintain the protein in a hypophosphorylated state. A protein phosphatase-2A-like activity has been reported to dephosphorylate KSP repeats in NFH (Veeranna et al., 1995) . However, attempts to dephosphorylate The neuronal cell bodies were manually separated from the neurites and subjected to Western blot analysis using the anti-N F H monoclonal antibody N52. pNFH and dpNFH refer to hyper-and hypophosphorylated NFH, respectively. Figure 5 . Distribution of phosphorylated N F H isoforms in DRG neurons. Localized DRG cultures were prepared as described in Materials and Methods and separated into cell body ( C)-and neurite ( N)-enriched fractions. The two subcellular fractions were subjected to Western blot analysis using the anti-N F H monoclonal antibodies N52, SM I 31, and SMI 34. pNFH and dpNFH refer to hyper-and hypophosphorylated NF H, respectively. A, DRG cultures were maintained for 20 d. C ell bodyand neurite-enriched fractions were harvested in equal volumes of SDSsample buffer, and the same volume was loaded in each lane. B, DRG cultures were maintained in the presence of antimitotic agents as described in Materials and Methods. C ell body-and neurite-enriched fractions were lysed in 2% SDS and 62.5 mM Tris, pH 6.8, protein concentrations were determined, and equal amounts of protein were loaded in each lane. (lanes 1, 3, 5, 7 ) and anticdk-5 (C-8) polyclonal antibody (lanes 2, 4, 6, 8) . The activity of cdk-5 was assayed with [␥- 32 P]ATP and histone H1. B, The cdk-5 immunoprecipitated from A was detected by Western blot analysis using anti-cdk-5 monoclonal antibody (DC17).
NFH in vitro to an extent that would alter its electrophoretic mobility using any of the major neuronal protein phosphatases-1, 2A, 2B, and 2C -were unsuccessf ul (Hisanaga et al., 1993a) . This discrepancy may be attributable to differences between the in vivo and in vitro conformations of N F H, to differences in substrate specificity conferred by regulatory subunits associated with the catalytic phosphatase subunit (Sola et al., 1991) , or to the involvement of a different protein phosphatase such as PP-X (Brewis et al., 1993) . In any case, our results are consistent with the presence of an N F H tail domain phosphatase in the neuronal perikaryon. This enzyme may be absent from or less active in axons, where N F H is highly phosphorylated.
We have also demonstrated that ERK s and SAPK␥ are equally distributed between the cell body and neurite compartments of DRG neurons. The localization of ERK s in neurites is consistent with a recent study demonstrating the axonal transport of these enzymes (Johanson et al., 1995) . Although SAPK s have been reported to phosphorylate primarily transcription factors (Cano and Mahadevan, 1995; Kyriakis and Avruch, 1996) , the axonal localization of SAPK␥ suggests that it may also be involved in the phosphorylation of cytoplasmic substrates, such as NFH.
C dk-5 is the only neuronal kinase (Hisanaga, 1993b; Miyasaka et al., 1993) , other than SAPK s, that has been shown to phosphorylate N F H to the point of reducing its mobility on SDS-PAGE to that of axonal N F H. C dk-5 has been reported to phosphorylate N F H in vitro to the extent of 3-5 moles (Miyasaka et al., 1993) or 10 moles (Hisanaga et al., 1993b) of phosphate per mole of N F H, preferentially at K SPX K repeats (where X is not an acidic residue) (Beaudette et al., 1993) . We have observed that neuritic N F H in cultured DRG neurons is highly phosphorylated despite the demonstrated lack of cdk-5 activity (see Fig. 6 ), which is likely to be because its activator ligand, p35/p25 (Lew et al., 1994; Tsai et al., 1994) , is not expressed in these neurons (Tsai et al., 1994) . This may explain the apparent sparing of DRG neurons in cdk-5-deficient mice, whereas many types of CNS neurons in these animals are adversely affected (Ohshima et al., 1996) . Consequently, it is possible that K SPX K motifs are not phosphorylated in DRG neurons, as is suggested by the finding that NF H is more highly phosphorylated in ventral root motor neurons than in dorsal root neurons (Soussan et al., 1996) . Cdk-5 is likely to be active in and required for motor neuron survival because the latter show a number of abnormalities in mice lacking the enzyme, including ballooned perikarya, dispersed Nissl substance, and cytoplasmic vacuoles (Ohshima et al., 1996) . N F H is reported to undergo high levels of phosphorylation in the initial axon segment, the site at which myelination begins (Hsieh et al., 1994; Nixon et al., 1994a) . We have demonstrated that N F H follows the normal pattern of phosphorylated isoform distribution in cultured DRG neurons despite the lack of myelination (see Fig. 5A ). Furthermore, cultures devoid of Schwann cells also exhibited the normal N F H phosphorylation profile (see Fig. 5B) . These experiments clearly demonstrate that phosphorylation of neuritic N F H is not initiated solely by cues stemming from Schwann cell -axon interactions. As mention above, there may be differences in phosphatase activity levels between the cell body and neuritic compartments. However, it is also likely that NF H-kinase(s) is (are) activated in the initial axon segment, and these enzymes conceivably could include SAPK s. Phosphorylation of the N F H tail domain does not occur exclusively during the entry of N Fs into axons. Phosphate addition continues during N F transport (Lewis and Nixon, 1988; Archer et al., 1994; Nixon et al., 1994b) , and regional differences in tail domain phosphorylation within myelinated axons have also been reported. There is a reduced level of NF phosphorylation at the nodes of Ranvier (Mata et al., 1992 ) and a decrease in axonal NFH phosphorylation in hypomyelinating transgenic or Trembler mice (de Waegh et al., 1992; Cole et al., 1994) . The latter observation indicates that axonal properties, including NFH phosphorylation, are modulated by signals transmitted from myelinating Schwann cells to axons. NFH phosphorylation in myelinated regions thus may be augmented through the activation of proline-directed kinases such as ERKs and SAPKs.
There is evidence suggesting that aberrant NF metabolism may be involved in the etiology of ALS (Côté et al., 1993; Xu et al., 1993) . Motor neurons containing abnormally hyperphosphorylated perikaryal NFH and proximal axonal enlargements filled with NFs are characteristic of the disease (Carpenter, 1968; Hirano et al., 1984; Manetto et al., 1988; Munoz et al., 1988; Sobue et al., 1990) . Furthermore, ALS is a neurodegenerative disease that targets the large, NF-rich motor neurons predominantly and large sensory neurons to a lesser degree (Tsukagoshi et al., 1979; Kawamura et al., 1981) . If NFs are involved in ALS pathogenesis, it is more likely because of an impairment of axonal transport rather than simple accumulation of NFs in the perikaryon (Collard et al., 1995; Marszalek et al., 1996) .
The mechanism underlying the axonal transport of NFs remains unsettled, although experiments with the neurotoxin ␤,␤Ј-iminodipropionitrile (IDPN) suggest that microtubules may be involved. IDPN causes NFs and microtubules to segregate (Griffin et al., 1978; Papasozomenos et al., 1981) and, at appropriate doses, blocks NF movement, but it has only a modest effect on the transport of microtubules (Griffin et al., 1978) . This causes large masses of NFs to accumulate in the proximal axon (Chou and Hartman, 1965) . It is interesting to note in this respect that NFH interacts with microtubules only when its tail domain is hypophosphorylated (Hisanaga et al., 1991 (Hisanaga et al., , 1993a Miyasaka, 1993) , suggesting that tail domain phosphorylation may be important in regulating the transport of NFs from the cell body to the axon. Aberrant hyperphosphorylation of perikaryal NFH in neurons subjected to some form of stress thus may be responsible for the formation of neurofilamentous accumulations that characterize many neurological diseases.
